Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites

NCT03665610 · clinicaltrials.gov ↗
COMPLETED
Status
212
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celgene